Actinogen Medical Eyes Future With New Options
Company Announcements

Actinogen Medical Eyes Future With New Options

Actinogen Medical Limited (AU:ACW) has released an update.

Actinogen Medical Limited has applied for quotation of a new class of listed options on the ASX, which will expire on September 30, 2027. A total of 174,375,001 of these options will be issued at $0.05 each on September 24, 2024. This move represents an opportunity for investors to engage with the company’s future on the stock market.

For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskActinogen Medical’s Promising Advances in Neurological Treatments
TipRanks Australian Auto-Generated NewsdeskActinogen Medical’s Promising Advances in Neurological Treatments
TipRanks Australian Auto-Generated NewsdeskActinogen Medical Secures $9 Million R&D Rebate Boost
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App